About Pharmland | JV Pharmland LLC

pharmland   it works!

We are improving health and quality of life outcomes, thanks to the best traditions and our own excellence in in medicine and pharmaceuticals

About Pharmland

Improving healthcare and quality of life

1998

Our company’s foundation

Pharmland was established as a Belarusian-Dutch joint venture in 1998, initially located in leased premises at Nesvizh Medical Preparations Plant. We began by producing infusion solutions in PVC containers, with an estimated volume of 330,000 packages per month. For the first time in the former Soviet Union, an infusion solution of isotonic sodium chloride, packaged in a PVC container, came off the assembly line of our young enterprise. Our innovative packaging solution has since been recognized by medical institutions in Belarus.

2003

Production of ELISA test systems

Working with with specialists at Belarusian State University and leading Russian manufacturers of immunoenzyme diagnostic test systems and reagents, Pharmland specialists developed immunoenzymatic reagent kits. That same year, we perfected their production.

2009

Opening of new liquid dosage production plant

In September 2009, we opened Pharmland’s new liquid medicines plant, focussing on solutions for injection and infusion, and concentrates for haemodialysis. $10 million were invested in the new plant, 4.5 million of which was spent on acquiring the most advanced equipment.

2011

New production of solid dosage medicines

Production began at a new workshop, manufacturing solid dosage medicines. This was the result of cooperation between an alliance of international pharmaceutical companies, including India’s Holden Medical Laboratories Pvt. Ltd., the Dutch Holden Medical B.V. and our own JV Pharmland LLC. Since then, the three companies have been jointly jointly developing new products and research, namely the search for, and selection of, high-quality pharmaceutical substances and auxiliary ingredients, and the production of ready-made dosage forms.

As a result of cooperation with our Dutch partners at Holden Medical, we perfected our production techniques for bioactive food supplements.

2014

Enteral nutrition production begins

Having fully developed the underlying composition and technology, the manufacture of enteral nutrition mixtures was started. Our products have included Enterolin Optimum, Enterolin high-protein and high-calorie, Enterolin with dietary fiber, Enterolin high-protein and high-calorie with dietary fiber.

2015

Pharmland received GMP and ISO 9001 certificates

Pharmland was awarded the national GMP certificate, regarding our work in infusion and injection production, tableted, encapsulated medicinal products, and syrups. We also received a certificate recognising our compliance with quality management requirements of ISO 9001 for medical device production sites.

2015

Beginning of a new investment project

The first domestic consumable materials for conducting plasmapheresis and thrombocytopheresis have been developed. A new facility, financed by investment was put into operation - a plant for the production of medicines based on blood plasma. The volume of investments amounted to $23 million.

The plant’s production capacity stretches to 650 thousand litres of plasma per year. At the new plant, Pharmland plans to perfect the production of albumin, immunoglobulins, coagulation factors VIII and IX.

2017

Registration of new medicines

The company registered and introduced into production new Oroseptin (INN-Phenol) and Miramistin medical sprays.
This year, our Sophir (INN - Sofosbuvir) medicinal product, manufactured in 400mg tablets, became one of the most effective means of comprehensive treatment of hepatitis C.

After years of work in the Belarusian market, JV Pharmland products,
          with their high quality and affordable prices,
          have earned the respect of health professionals, and consumer trust.
          This is guaranteed by our Dutch control laboratory,
          where the quality control of finished out medicinal forms and substances is performed.
          Carrying out a multi-step control of its products,
          Pharmland is convinced that it guarantees Belarusian buyers high product quality,
          and, as such, and the desired medicinal effect.

Ivan Logovoy
Co-owner and chairman of the board of directors of Pharmland

Pharmland today

7000 м2 of production space
5 production
lines
140 items
in production
3 million patients are
treated with Pharmland
medicines annually